ONO-2333Ms

· Ono Pharma USA Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ONO-2333Ms, covering 2023-11-28 to 2023-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder [Phase 2]